Centrum Farmakoekonomiki

Ewa Orlewska. Podstawy Farmakoekonomiki. Unimed , Warszawa 1999; textbook (Polish)

Podstawy Farmakoekonomiki (Principles in Pharmacoeconomics), by Ewa Orlewska MD, PhD, covers all aspects of pharmacoeconomics and outcomes research, including rationale of using pharmacoeconomics in health care delivery, concepts (e.g. opportunity cost, incremental analysis, discounting and sensitivity analysis, modeling, decision analysis), common methodology, application and impact on the healthcare delivery system. Advantages and disadvantages of the various types of analyses (CMA, CEA, CBA, CUA, cost of illness study) are presented using the practical example. Graphs, illustrations, and tables are used frequently to illustrate major concepts. The textbook is addressed to anyone involved in undertaking of economic evaluation of health care programs or interpreting their results in medical decision making.

Ewa Orlewska, Elżbieta Nowakowska. Farmakoekonomika dla studentów i absolwentów akademii medycznych (Pharmacoeconomics for students and graduetes of Medical Universities); Wydawnictwo Akademii Medycznej im Karola Marcinkowskiegow Poznaniu (Medical University Publishing House), Poznan 2003, textbook (Polish).

Farmakoekonomika dla studentów i absolwentów akademii medycznych (Pharmacoeconomics for students and graduete of Medical Universities), by Ewa Orlewska MD, PhD and Professor Elżbieta Nowakowska MS, PhD is the comprehensive presentation of all key issues in the methodology of measurement and valuation of costs and outcomes of health care programs. The topics covered in the textbook are: definitions of costs and outcomes in economic evaluation, the methodological features of the basic forms of pharmacoeconomic analyses, decision rules in cost-effectiveness analysis, theory and practice of measuring preferences with particular emphasis on its use in economic evaluation, useful guidance on the construction and evaluation of decision analytic models, guidelines for conducting pharmacoeconomic evaluations, cost calculation in economic evaluation of health care programmes and conducting financial analysis (Budget Impact Analysis). It is designed primarily for students and graduetes of Medical Universities, but may serve as a reference tool for to anyone involved in undertaking of economic evaluation of health care programs or interpreting their results in medical decision making.

Ewa Orlewska, Marcin Czech. Słownik farmakoekonomiczny (Dictionary of Pharmacoeconomics. 2nd ed. Unimed, Warszawa, 2002.

Słownik farmakoekonomiczny (Dictionary of Pharmacoeconomics) - second edition, by Ewa Orlewska, PhD, MD and Marcin Czech PhD, MD, MBA includes the most important terms and their brief definitions covering the field of pharmacoeconomics, health economics, health care management and regulations, health- related quality of life and outcomes research. It is supplemented by selected terms concerning clinical trials, macroeconomics, financial analysis, cost accounting and statistics. All the terms are listed in alphabetic order (in Polish) with their English translations given in brackets. English terms are listed in the alphabetic order at the end of the publication. It is user-friendly lexicon which may serve as a reference tool for the practitioners of pharmacoeconomics and outcomes research as well as for users of pharmacoeconomic analyses.


	main page research cooperation education guidelines journals books		Ewa Orlewska. Podstawy Farmakoekonomiki. Unimed , Warszawa 1999; textbook (Polish) Podstawy Farmakoekonomiki (Principles in Pharmacoeconomics), by Ewa Orlewska MD, PhD, covers all aspects of pharmacoeconomics and outcomes research, including rationale of using pharmacoeconomics in health care delivery, concepts (e.g. opportunity cost, incremental analysis, discounting and sensitivity analysis, modeling, decision analysis), common methodology, application and impact on the healthcare delivery system. Advantages and disadvantages of the various types of analyses (CMA, CEA, CBA, CUA, cost of illness study) are presented using the practical example. Graphs, illustrations, and tables are used frequently to illustrate major concepts. The textbook is addressed to anyone involved in undertaking of economic evaluation of health care programs or interpreting their results in medical decision making. Ewa Orlewska, Elżbieta Nowakowska. Farmakoekonomika dla studentów i absolwentów akademii medycznych (Pharmacoeconomics for students and graduetes of Medical Universities); Wydawnictwo Akademii Medycznej im Karola Marcinkowskiegow Poznaniu (Medical University Publishing House), Poznan 2003, textbook (Polish). Farmakoekonomika dla studentów i absolwentów akademii medycznych (Pharmacoeconomics for students and graduete of Medical Universities), by Ewa Orlewska MD, PhD and Professor Elżbieta Nowakowska MS, PhD is the comprehensive presentation of all key issues in the methodology of measurement and valuation of costs and outcomes of health care programs. The topics covered in the textbook are: definitions of costs and outcomes in economic evaluation, the methodological features of the basic forms of pharmacoeconomic analyses, decision rules in cost-effectiveness analysis, theory and practice of measuring preferences with particular emphasis on its use in economic evaluation, useful guidance on the construction and evaluation of decision analytic models, guidelines for conducting pharmacoeconomic evaluations, cost calculation in economic evaluation of health care programmes and conducting financial analysis (Budget Impact Analysis). It is designed primarily for students and graduetes of Medical Universities, but may serve as a reference tool for to anyone involved in undertaking of economic evaluation of health care programs or interpreting their results in medical decision making. Ewa Orlewska, Marcin Czech. Słownik farmakoekonomiczny (Dictionary of Pharmacoeconomics. 2nd ed. Unimed, Warszawa, 2002. Słownik farmakoekonomiczny (Dictionary of Pharmacoeconomics) - second edition, by Ewa Orlewska, PhD, MD and Marcin Czech PhD, MD, MBA includes the most important terms and their brief definitions covering the field of pharmacoeconomics, health economics, health care management and regulations, health- related quality of life and outcomes research. It is supplemented by selected terms concerning clinical trials, macroeconomics, financial analysis, cost accounting and statistics. All the terms are listed in alphabetic order (in Polish) with their English translations given in brackets. English terms are listed in the alphabetic order at the end of the publication. It is user-friendly lexicon which may serve as a reference tool for the practitioners of pharmacoeconomics and outcomes research as well as for users of pharmacoeconomic analyses.

	Centrum Farmakoekonomiki © 2006